Beth Altman Joins Papyrus Therapeutics Inc.
Beth Altman, former managing partner at accounting firm KPMG LLP San Diego, has joined Papyrus Therapeutics Inc. as an independent director of the Company's Board of Directors and as Chair of the Audit Committee.
- Beth Altman, former managing partner at accounting firm KPMG LLP San Diego, has joined Papyrus Therapeutics Inc. as an independent director of the Company's Board of Directors and as Chair of the Audit Committee.
- Beth has more than 27 years of experience in accounting, finance, management, business development, strategic planning and corporate governance.
- CEO Dr Paul Blake stated, "I am delighted that Beth is joining Papyrus Therapeutics.
- About Papyrus Therapeutics Inc.: Papyrus Therapeutics, Inc. (West Chester, PA, USA) is an emerging biopharma company developing novel tumor suppressor-based therapies.